Meyka Pro banner
Royalty Pharma plc

Stay Updated with the Latest Royalty Pharma plc RPRX News in Real Time

Find RPRX news now at Meyka AI. Stay informed with the latest Royalty Pharma plc stocks updates, including price news, market analysis, and expert insights.

RPRXNASDAQ
HealthcareMedical - Pharmaceuticals
$61.31
$0.73(1.21%)
U.S. Market opens in 54h 32m
Japan’s Whistleblowers Face Retaliation: New Law Tightens Protections in December
📅 1 day ago

Japan’s Whistleblowers Face Retaliation: New Law Tightens Protections in December

Japan’s amended Whistleblower Protection Act, effective December 2026, shifts burden of proof to employers and adds criminal penalties. But gaps remain for harassment and demotion cases.

Read more 12
Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection
📅 2 days ago

Strides Pharma Stock Rallies 10% as USFDA Concludes Bengaluru Inspection

Strides Pharma shares surged 11% to ₹1,055.90 on the BSE on August 20, 2026. The rally followed news that the company’s flagship Bengaluru facility received a USFDA Establishment Inspection Report. That report confirms successful closure of a cGMP inspection conducted in May 2026. Heavy trading volumes accompanied the sharp intraday move. What the USFDA EIR…

Read more 12
Schott Pharma (ETR: 1SXP) Shares Jump 4% as Barclays Upgrades Stock to Overweight on Growth Inflection
📅 4 days ago

Schott Pharma (ETR: 1SXP) Shares Jump 4% as Barclays Upgrades Stock to Overweight on Growth Inflection

Schott Pharma shares jumped as much as 6.5% on August 18, 2026, hitting a new 52-week high of €23. Barclays upgraded the stock to “overweight” from “equal weight” and raised its price target to €27 from €16. Analyst Jonathon Unwin cited a genuine growth inflection after three years of declining earnings estimates. The upgrade reflects…

Read more 12
Gland Pharma (NSE: GLAND) Shares Surge 12% to 52-Week High of ₹2,969.90 After Strong Q1 FY27 Results
📅 11 days ago

Gland Pharma (NSE: GLAND) Shares Surge 12% to 52-Week High of ₹2,969.90 After Strong Q1 FY27 Results

Gland Pharma shares jumped nearly 12% on August 11, 2026, hitting a fresh 52-week high of ₹2,969.90 after the company reported strong Q1 FY27 results. Revenue rose 19.5% year on year to ₹1,800 crore, while net profit surged 47% to ₹317 crore. Strong US sales and rising CDMO revenue supported the quarter. The sharp rise…

Read more 12
Goodwin Mulls Sale of Defence Engineering Division Supplying Submarine and Warship Components
📅 15 days ago

Goodwin Mulls Sale of Defence Engineering Division Supplying Submarine and Warship Components

On August 7, 2026, British engineering company Goodwin confirmed it is reviewing options for its defence engineering division, including the possible sale of a substantial part of the business. The division supplies critical components for UK and U.S. submarines and warships, making the announcement one of the most closely watched developments in the defence sector….

Read more 12
Holidays Disrupted as 11 UK Travel Companies Collapse in Recent Months
📅 17 days ago

Holidays Disrupted as 11 UK Travel Companies Collapse in Recent Months

UK travel firms have collapsed at an alarming rate in 2026. Since January, 11 operators have entered liquidation or ceased trading, according to industry reports. The wave spans coach tours, cruise specialists, and flight-and-hotel package providers. Thousands of holidaymakers now face cancelled trips and refund battles, while the sector confronts its sharpest instability in years….

Read more 12
Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24
📅 29 days ago

Generic Zyrtec Recalled Over Heartburn Drug Contamination July 24

Generic Zyrtec recalled nationwide due to contamination with heartburn drug ranitidine. Four lot numbers affected. No illnesses reported yet. Check your bottles.

Read more 12
HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership
📅 29 days ago

HSBC (LSE: HSBA) to Sell Singapore Insurance Unit for £1.6B, Signs 15-Year Allianz Partnership

HSBC agreed to sell its Singapore life and health insurance business to Allianz on July 24, 2026. The deal values HSBC Life Singapore at S$2.7 billion, or roughly £1.6 billion. It will also enter a 15-year exclusive bancassurance partnership with the German insurer. The transaction generates a pre-tax gain of $1.8 billion and lifts HSBC’s…

Read more 12
Barclays Plc Trading Chief Pushes Team to Close Gap With Wall Street
📅 29 days ago

Barclays Plc Trading Chief Pushes Team to Close Gap With Wall Street

Wall Street banks continue to widen their lead in global trading, increasing the pressure on European competitors. On July 24, 2026, reports said Barclays Plc’s trading chief asked staff to narrow the performance gap with major U.S. banks after another strong quarter for the industry.  Higher market volatility, steady deal activity, and strong client demand…

Read more 12

RPRX News FAQ